|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.38 USD | -1.44% |
|
+4.55% | -13.39% |
| 07-30 | Celcuity Announces FDA Approval And NCCN Guidelines Inclusion For REVTORPYK In Combination With Fulvestrant With Or Without Palbociclib | CI |
| 07-15 | Celcuity Inc. - Special Call |
| Market Cap | 4.21B 3.65B 3.4B 3.12B 5.9B 402B 6B 40.06B 15.73B 200B 15.82B 15.47B 663B | P/E 2026 * |
-20.5x | P/E 2027 * | -171x |
|---|---|---|---|---|---|
| Enterprise Value | 4.21B 3.65B 3.4B 3.12B 5.9B 402B 6B 40.06B 15.73B 200B 15.82B 15.47B 663B | EV / Sales 2026 * |
108x | EV / Sales 2027 * | 10.7x |
| Free-Float |
89.97% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Celcuity Inc.
| 1 day | -1.44% | ||
| 1 week | +4.55% | ||
| 1 month | -17.43% | ||
| 3 months | -28.82% | ||
| 6 months | -21.06% | ||
| Current year | -13.39% |
| 1 week | 78.6 |  | 88.5 |
| 1 month | 78.6 | | 117.21 |
| Current year | 78.6 | | 151.02 |
| 1 year | 38.93 | | 151.02 |
| 3 years | 7.58 | | 151.02 |
| 5 years | 4.81 | | 151.02 |
| 10 years | 4.03 | | 151.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lance Laing
CTO | Chief Tech/Sci/R&D Officer | 64 | 2011-12-31 |
Brian Sullivan
CEO | Chief Executive Officer | 64 | 2011-12-31 |
Vicky Hahne
DFI | Director of Finance/CFO | 59 | 2017-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Brian Sullivan
CHM | Chairman | 64 | 2011-12-31 |
Lance Laing
BRD | Director/Board Member | 64 | 2011-12-31 |
David Dalvey
BRD | Director/Board Member | 67 | 2014-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/14/26 | Baker Bros. Advisors LP
| Sell | Company | -3,100,000 | 6.6996% | |
| 6/2/26 | Fiscal year | Founder | 2,000 | 0.0043% | ||
| 4/9/26 | Don | Director | 10,000 | 0.0216% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.44% | +4.55% | +120.55% | +774.29% | 4.21B | |
| +2.35% | +2.74% | +33.41% | +79.20% | 56.54B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.6B | |
| -2.44% | +1.40% | -15.74% | -16.80% | 22.91B | |
| -2.85% | -7.78% | -8.09% | +346.36% | 21.37B | |
| +2.49% | -0.92% | +20.31% | -12.15% | 20.27B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.56B | |
| +0.58% | -5.88% | +16.30% | +540.37% | 14.75B | |
| -5.25% | -4.23% | +46.41% | +169.05% | 13.33B | |
| +3.41% | -6.61% | +163.08% | +280.43% | 13.53B | |
| Average | -0.26% | -2.96% | +43.08% | +219.04% | 23.81B | |
| Weighted average by Cap. | +0.20% | -2.83% | +30.30% | +131.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.92M 33.76M 31.42M 28.87M 54.55M 3.71B 55.43M 370M 145M 1.85B 146M 143M 6.13B | 393M 341M 317M 292M 551M 37.51B 560M 3.74B 1.47B 18.68B 1.48B 1.44B 61.89B |
| Net income | -221M -192M -178M -164M -310M -21.09B -315M -2.1B -825M -10.5B -830M -812M -34.8B | -34.43M -29.87M -27.8M -25.54M -48.26M -3.28B -49.04M -327M -129M -1.64B -129M -126M -5.42B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$86.38 | -1.44% | 677,931 |
| 26-07-30 | US$87.64 | +5.26% | 1,322,667 |
| 26-07-29 | US$83.26 | +0.97% | 1,371,603 |
| 26-07-28 | US$82.46 | +0.23% | 1,962,109 |
| 26-07-27 | US$82.27 | -0.42% | 1,763,276 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CELC Stock
Select your edition
All financial news and data tailored to specific country editions
